Results 81 to 90 of about 36,516 (242)

Clinicopathology of chondrosarcoma.

open access: yesActa medica Okayama, 1996
We conducted a clinicopathological analysis of chondrosarcomas in 17 patients treated in our institute. The 5- and 10-year overall survival rates of the patients were 72.3% and 61.9%, respectively. The significant prognostic factors were size and histologic grade of the tumor.
Uchida, Yoichiro   +5 more
openaire   +3 more sources

Intracortical Chondrosarcoma: a Case Report

open access: yesActa Medica Iranica, 2014
Chondrosarcoma is the second most common primary mesenchymal malignant tumor of the bone. The most common form is central chondrosarcoma and the rarest is intracortical chondrosarcoma. Here, we describe the clinical, pathological, and imaging features of
Khodamorad Jamshidi   +2 more
doaj  

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma

open access: yesCancer Management and Research, 2021
Changbao Chen,1 Hua Zhou,2 Xiaolin Zhang,1 Zhongjun Liu,2 Xinlong Ma1 1Department of Spinal Surgery, Tianjin Hospital, Tianjin, 300211, People’s Republic of China; 2Department of Orthopaedic Surgery, Peking University Third Hospital, Beijing ...
Chen C, Zhou H, Zhang X, Liu Z, Ma X
doaj  

Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy

open access: yesThe Journal of Pathology: Clinical Research, Volume 12, Issue 5, September 2026.
Abstract NTRK fusions drive the pathogenesis of a distinctive group of mesenchymal neoplasms with significant impact on classification and targeted therapy. However, unexpected NTRK fusions have been reported in other sarcoma entities, raising uncertainty over their specificity and clinical management.
Mohamed A Yakoub   +4 more
wiley   +1 more source

Description of the immune microenvironment of chondrosarcoma and contribution to progression

open access: yesOncoImmunology, 2017
Chondrosarcoma (CHS) is a rare bone malignancy characterized by its resistance to conventional systemic and radiation therapies. Whether immunotherapy targeting immune checkpoints may be active in these tumors remains unknown.
François A. Simard   +7 more
doaj   +1 more source

Chondrosarcoma of the Proximal Phalanx of the Fourth Digit: A Rare Location

open access: yesCase Reports in Oncology, 2012
Introduction: Cartilaginous tumors involving the small bones of the hands and feet are usually benign such as enchondroma, chondromyxoid fibroma and chondroblastoma.
Thivi Vasilakaki   +8 more
doaj   +1 more source

Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

open access: yesJournal of Cancer, 2019
Purpose: Chondrosarcoma with metastatic disease has a very poor prognosis. However, the prognosis and potential prognostic factors of patients with primary chondrosarcoma of bone and metastasis at presentation have not been documented because of its ...
Zhan Wang   +8 more
semanticscholar   +1 more source

High‐Resolution Genomic Characterization of WAGR Spectrum Disorder: Insights From a Novel Cohort and Literature Synthesis, and Validation of Patient‐Reported Data

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 9, Page 1989-1999, September 2026.
ABSTRACT WAGR spectrum disorder (WAGRSD) is an ultra‐rare congenital disorder caused by heterozygous deletion of chromosome 11p13. While classically associated with Wilms tumor, Aniridia, Genitourinary anomalies, and a Range of developmental delays, accurate delineation of the deletion is critical for prognosis because the phenotypic spectrum extends ...
Andrew M. George   +11 more
wiley   +1 more source

Labial Cartilaginous Choristoma Mimicking a Mucocele: A Rare Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Choristomas are non‐neoplastic, tumor‐like lesions composed of histologically normal tissue in ectopic locations, though their exact pathogenesis remains unknown. Labial cartilaginous choristoma is an exceptionally rare benign lesion that clinically mimics common lip swellings, posing a diagnostic challenge. A 25‐year‐old male presented with a
Kimia Hafezimotlagh   +4 more
wiley   +1 more source

BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors

open access: yesBMC Cancer, 2012
Background As major regulators of normal chondrogenesis, the bone morphogenic protein (BMP) and transforming growth factor β (TGFB) signaling pathways may be involved in the development and progression of central chondrosarcoma. In order to uncover their
Boeuf Stephane   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy